841 results on '"Mitsikostas, Dimos"'
Search Results
2. The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders
Catalog
Books, media, physical & digital resources
3. Continuing evolution of migraine-specific therapies — targeting migraine with precision and persistence
4. Instrumental Occlusal Analysis in Migraine Patients: A Quantitative Cross Sectional Study
5. Evidence-based symptomatic treatment of migraine
6. Nocebos in migraine
7. Headache disorders in multiple sclerosis: Is there an association? A systematic review and meta-analysis
8. A Prospective, Observational Study Assessing Effectiveness, Safety, and QoL of Greek Patients with Multiple Sclerosis Under Treatment with Fingolimod
9. Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030
10. COVID-19 vaccination-related headache showed two different clusters in the long-term course: a prospective multicenter follow-up study (COVA-Head Study)
11. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice
12. Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece
13. Understanding frontal lobe function in epilepsy: Juvenile myoclonic epilepsy vs. frontal lobe epilepsy
14. Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regression
15. Unveiling GFAP Astrocytopathy: Insights from Case Studies and a Comprehensive Review of the Literature.
16. Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review
17. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
18. Galcanezumab Add-on in Refractory Cluster Headache
19. COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
20. Diagnosis and management of migraine in ten steps
21. Migraine: integrated approaches to clinical management and emerging treatments
22. Nocebo in Headache Treatment
23. Implications of Placebos and Nocebos in Clinical Practice
24. Definition of Refractory Chronic Headache
25. Validity and reliability of the Greek version of the neurogenic bladder symptom score (NBSS) questionnaire in a sample of Greek patients with multiple sclerosis
26. Galcanezumab add-on in refractory cluster headache. A case series.
27. Instrumental Occlusal Analysis in Migraine Patients: A Quantitative Cross Sectional Study.
28. Safety, Tolerability, and Nocebo Phenomena During Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Placebo-Controlled Clinical Trials
29. Lateralization of Insular Ischemic Stroke is Not Associated With Any Stroke Clinical Outcomes: The Athens Stroke Registry
30. Reply to the letter: Headaches during/after SARS‐CoV‐2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S
31. Current and Emerging Treatment Options in Pediatric Onset Multiple Sclerosis
32. Depression and Anxiety Symptoms in Headache Disorders: An Observational, Cross-Sectional Study
33. Placebo responses vary by route of administration in migraine prevention trials. What does this mean?
34. Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review
35. A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study
36. Therapies targeting CGRP signaling for medication overuse headache
37. Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures:post hoc analysis of the DELIVER randomized clinical trial
38. The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution:from headache burden to a global action plan for headache disorders
39. Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies
40. IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naïve Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial
41. Current understanding and future perspectives of brain–heart–kidney axis in psoriatic arthritis
42. Placebo and nocebo phenomena in anti- CGRP monoclonal antibody trials for migraine prevention: a meta-analysis
43. Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population
44. Headache and Pregnancy
45. New players in the preventive treatment of migraine
46. Tension-type headache
47. Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatments
48. Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trials
49. Onabotulinumtoxina in the Prevention of Migraine in Pediatric Population: A Systematic Review.
50. Impact of fremanezumab treatment on disability outcomes in patients with migraine and major depressive disorder: Results of the UNITE study
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.